Juan Young

Research Associate Professor

  • 2442 Citations
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Juan Young is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Rett Syndrome Medicine & Life Sciences
Methyl-CpG-Binding Protein 2 Medicine & Life Sciences
Mutation Medicine & Life Sciences
Phenotype Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Smith-Magenis Syndrome Medicine & Life Sciences
DNA Methylation Medicine & Life Sciences
Methylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 2442 Citations
  • 41 Article
  • 1 Review article

coMethDMR: accurate identification of co-methylated and differentially methylated regions in epigenome-wide association studies with continuous phenotypes

Gomez, L., Odom, G. J., Young, J. I., Martin, E. R., Liu, L., Chen, X., Griswold, A. J., Gao, Z., Zhang, L. & Wang, L., Sep 26 2019, In : Nucleic acids research. 47, 17, p. e98

Research output: Contribution to journalArticle

Open Access
Methylation
DNA Methylation
Phenotype
Genome
Technology
1 Citation (Scopus)

Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease

Young, J. I., Sivasankaran, S. K., Wang, L., Ali, A., Mehta, A., Davis, D. A., Dykxhoorn, D. M., Petito, C. K., Beecham, G. W., Martin, E. R., Mash, D. C., Pericak-Vance, M., Scott, W. K., Montine, T. J. & Vance, J. M., Aug 1 2019, In : Neurology: Genetics. 5, 4, 342.

Research output: Contribution to journalArticle

Open Access
DNA Methylation
Epigenomics
Parkinson Disease
Genome
Brain
2 Citations (Scopus)

Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development

Fuse, M. A., Dinh, C. T., Vitte, J., Kirkpatrick, J., Mindos, T., Plati, S. K., Young, J., Huang, J., Carlstedt, A., Franco, M. C., Brnjos, K., Nagamoto, J., Petrilli, A. M., Copik, A. J., Soulakova, J. N., Bracho, O., Yan, D., Mittal, R., Shen, R., Telischi, F. F. & 5 others, Morrison, H., Giovannini, M., Liu, X. Z., Chang, L. S. & Fernandez-Valle, C., Mar 18 2019, In : Neuro-Oncology. 21, 4, p. 486-497 12 p.

Research output: Contribution to journalArticle

Neurofibromatosis 2
Neurilemmoma
Drug Resistance
Acoustic Neuroma
Neurofibromin 2
1 Citation (Scopus)

Resveratrol Preconditioning Induces Genomic and Metabolic Adaptations within the Long-Term Window of Cerebral Ischemic Tolerance Leading to Bioenergetic Efficiency

Khoury, N., Xu, J., Stegelmann, S. D., Jackson, C. W., Koronowski, K. B., Dave, K. R., Young, J. & Perez-Pinzon, M., Jan 1 2018, (Accepted/In press) In : Molecular Neurobiology.

Research output: Contribution to journalArticle

Energy Metabolism
Down-Regulation
Brain Ischemia
Adenosine Triphosphate
Cell Respiration
4 Citations (Scopus)

The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning

Khoury, N., Koronowski, K. B., Young, J. & Perez-Pinzon, M., Mar 10 2018, In : Antioxidants and Redox Signaling. 28, 8, p. 691-710 20 p.

Research output: Contribution to journalReview article

Sirtuins
Brain Ischemia
NAD
Modulators
Pharmacology